✦ LIBER ✦

CD77 as a biomarker for effectiveness of enzymatic replacement therapy in Fabry disease

✍ Scribed by Semiramis Hadad; Ester Miranda Pereira; Adalberto Socorro da Silva; Anaregina de Sousa Araújo; Henrique César Saraiva de Arêa Leão Costa Filho; Fernando Ferraz do Nascimento; Raimundo Nonato da Silva

Book ID: 116989164
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 55 KB
Volume: 102
Category: Article
ISSN: 1096-7192
DOI: 10.1016/j.ymgme.2010.11.067

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

CD77 as a Biomarker for Effectiveness of

CD77 as a Biomarker for Effectiveness of Enzymatic Replacement Therapy in Fabry Disease

✍ Ester Miranda Pereira; Adalberto Socorro da Silva; Semiramis Jamil Hadad do Mont 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Cost-effectiveness of Enzyme Replacement

Cost-effectiveness of Enzyme Replacement Therapy for Fabry Disease

✍ Saskia Rombach; Marcel Dijkgraaf; Gabor Linthorst; Carla Hollak 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Cost-effectiveness of enzyme replacement

Cost-effectiveness of enzyme replacement therapy for Fabry disease

✍ Saskia M Rombach, Carla EM Hollak, Gabor E Linthorst… 📂 Article 📅 2013 🏛 BioMed Central 🌐 English ⚖ 263 KB

Tissue and plasma globotriaosylsphingosi

Tissue and plasma globotriaosylsphingosine could be a biomarker for assessing enzyme replacement therapy for Fabry disease

✍ Tadayasu Togawa; Ikuo Kawashima; Takashi Kodama; Takahiro Tsukimura; Toshihiro S 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 400 KB

Hearing loss in Fabry disease: the effec

Hearing loss in Fabry disease: the effect of α-galactosidase A replacement therapy

✍ D Hajioff; Y Enever; R Quiney; A Mehta 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 172 KB

Clinical benefit of enzyme replacement t

Clinical benefit of enzyme replacement therapy in Fabry disease

✍ Breunig, F; Weidemann, F; Strotmann, J; Knoll, A; Wanner, C 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 113 KB